The aim of the symposium is to bring together the pediatric cancer community to discuss advances in our understanding of the origins and causes of cancer development and the associated therapeutic perspectives.
The symposium will address several areas of cancer research, including epidemiological and genetic risk factors, the role of development in tumor initiation, modelising the complex biology of tumors development, and novel therapeutic
strategies.
Target audience: physicians, clinicians, basic researchers, biologists, trainees, medical students.
Confirmed speakers are indicated below.
Confirmed speakers
Scott A. Armstrong
Dana-Farber Cancer Institute, USA
Franck Bourdeaut
Institut Curie, France
Guillaume Canaud
Hôpital Necker, France
Mario Capasso
University of Naples Frederico II, Italy
Céline Delloye-Bourgeois
CRCL, France
Jarno Drost
Princess Maxima Center, Netherlands
Friederike Erdmann
IMBEI, Germany
Mariella Filbin
Boston Children’s Hospital, USA
Alain Fischer
Institut Imagine, France
Birgit Geoerger
Gustave Roussy, France
Florent Ginhoux
Gustave Roussy, France
Cédric Maurange
IBDM, France
Katrin Ottersbach
University of Edinburgh, UK
Michael D. Taylor
Baylor College of Medicine – Texas Children’s Hospital, Houston
Program
Wednesday May 29 th
12:00-19:00
12:00-13:00
Welcome coffee
13:00-13:35
How genetic defects of the immune system predispose to cancer
Alain Fischer, Institut Imagine, Paris, France
Session 1 – Risk factors in childhood cancers
13:35-14:10
Unravelling Genetic Predisposition to Neuroblastoma: Implications and Relevance in Clinical Settings
Mario Capasso, University of Naples Federico II CEINGE Biotecnologie Avanzate, Italy
14:10-14:30
Environmental risk factors of childhood cancers – recent results of the GEOCAP project
Stéphanie Goujon, Hôpital Brousse, Villejuif, France
14:30-14:45
Wilms tumour: a systematic review and meta-analysis of environmental risk factors
Felix Onyije, Centre international de recherche sur le cancer, Lyon, France
14:45-15:00
Selected talks
15:00-15:15
The synergistic impact of exposures to mycotoxins and Epstein Barr virus (EBV) at early stages of Burkitt lymphomagenesis
Rita Khoueiry, Centre international de recherche sur le cancer, Lyon, France
15:15-15:30
Origins of Second Malignancies in Children
Mònica Sánchez-Guixé, Institute for research in biomedicine, Barcelona
15:30-16:00
Coffee break
16:00-16:35
Childhood cancer incidence and paediatric cancer care during the COVID-19 pandemic in Germany: Any new aetiological insights from the pandemic?
Friederike Erdmann, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center of the Johannes Gutenberg University Mainz, Germany
16:35-17:00
Molecular and genetic basis of Epstein Barr virus-associated childhood lymphoma
Sylvain Latour, Institut Imagine, Paris, France
17:00-19:00
Poster Session
Registration
Registration fees (3-day admission, including light lunches):
-Regular: 150 €
-Junior (student, post-doc, engineer, 36 years and younger): 50 €
Please fill in the form with the following information:
– Congress name/Workshop: “PEDIAC symposium 2024”
– Beneficiary of invoice: “INSERM DR PARIS IDF SUD”
For general information, please contact symposium2024@programme-pediac.com
For specific information regarding order forms please contact grepa-paris11@inserm.fr
Pratical information
Location: the symposium will be held at Institut Imagine, 24 Boulevard du Montparnasse, Paris 75015. Join us at the Auditorium on the 6 th floor.
Public transport
METRO:
-Line 12, station Falguière
-Lines 10 et 13, station Duroc
-Lines 4, 6, 12 and 13, station Montparnasse
TGV station Montparnasse
BUS Line 89 station Maine – Vaugirard
PLANE take transportation from Charles de Gaulle and Orly airports
Sponsors
We greatly appreciate the support from our sponsors.
